Revvity tazocine, -,250µci (9.25mbq

Revvity 250 µCi quantity of (+)-Pentazocine, [Ring-1,3-³H]-, is available for your research. Pentazocine functions as a sigma σ1 receptor agonist, where it has been shown to inhibit the outward current of potassium ions (K+). It is a known analgesic used to treat pain. - REVPFZ (Additional S&H Or Hazmat Fees May Apply)

Revvity We offer both agonist and antagonist radioligands for autoradiographic visualization or performing saturation and competition assays to determine receptor expression levels (B_max), dissociation constants (K_d), association and dissociation rates (k_on and k_off), and inhibitor constants (K_i) for a variety of receptors. We develop our radioligands to the highest specific activity possible and provide high purity resulting in low non-specific binding products. Each of our ultra-pure radioligands is fully characterized for pharmacological action and validated in receptor binding assays. - REVPFZ (Additional S&H Or Hazmat Fees May Apply)

Revvity Radiolabeled ligands remain the most sensitive method for probing receptor binding biology; yielding unprecedented sensitivity gives results that technicians and scientists can trust. For over 50 years, Revvity has been a leading supplier of New England Nuclear (NEN) radiochemicals, liquid scintillation cocktails, vials and nuclear counting detection instruments. - REVPFZ (Additional S&H Or Hazmat Fees May Apply)

Revvity References for NET1056: - REVPFZ (Additional S&H Or Hazmat Fees May Apply)

Dhwanil A. Dalwadi, Seongcheol Kim, John A. Schetz, Activation of the sigma-1 receptor by haloperidol metabolites facilitates brain-derived neurotrophic factor secretion from human astroglia, In Neurochemistry International, Volume 105, 2017, Pages 21-31.José Luis Díaz, Ute Christmann, Ariadna Fernández, Antoni Torrens, Adriana Port, Rosalia Pascual, Inés Álvarez, Javier Burgueño, Xavier Monroy, Ana Montero, Ariadna Balada, José Miguel Vela, and Carmen Almansa. Synthesis and Structure–Activity Relationship Study of a New Series of Selective σ1 Receptor Ligands for the Treatment of Pain: 4-Aminotriazoles, In Journal of Medicinal Chemistry, Volume 58, Issue 5, 2015, Pages 2441-2451.